Therapeutic strategies in pneumonia: going beyond antibiotics

European Respiratory Review : an Official Journal of the European Respiratory Society
H C Müller-RedetzkyM Witzenrath

Abstract

Dysregulation of the innate immune system drives lung injury and its systemic sequelae due to breakdown of vascular barrier function, harmful hyperinflammation and microcirculatory failure, which contribute to the unfavourable outcome of patients with severe pneumonia. A variety of promising therapeutic targets have been identified and numerous innovative therapeutic approaches demonstrated to improve lung injury in experimental preclinical studies. However, at present specific preventive or curative strategies for the treatment of lung failure in pneumonia in addition to antibiotics are still missing. The aim of this mini-review is to give a short overview of some, but not all, adjuvant therapeutic strategies for pneumonia and its most important complications, sepsis and acute respiratory distress syndrome, and briefly discuss future perspectives.

References

Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·S KudohM Ando
May 4, 2000·The New England Journal of Medicine·UNKNOWN Acute Respiratory Distress Syndrome NetworkArthur Wheeler
Mar 22, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F G AraujoJ S Remington
Jul 18, 2002·American Journal of Respiratory and Critical Care Medicine·Jeffrey J PresneillJohn W Wilson
Oct 5, 2002·Circulation Research·Stefan HippenstielNorbert Suttorp
Feb 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·José A MartínezJosep Mensa
Feb 25, 2003·The Journal of Infectious Diseases·Melvyn LynnF Gilbert McMahon
Feb 27, 2003·The Journal of Pharmacology and Experimental Therapeutics·Maureen MullarkeyDaniel P Rossignol
Jul 15, 2003·Immunologic Research·Dimitrios MastellosJohn D Lambris
Nov 6, 2003·American Journal of Surgery·Paul J MathesonR Neal Garrison
Dec 19, 2003·The New England Journal of Medicine·Joseph S M PeirisKlaus Stöhr
May 7, 2004·The Journal of Endocrinology·B M Y CheungF Tang
Nov 24, 2004·American Journal of Respiratory and Critical Care Medicine·Marco ConfalonieriG Umberto Meduri
Dec 8, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jackeline AgorretaMercedes Garayoa
Dec 22, 2004·Circulation·Bernhard WitzenbichlerCarsten Tschope
Feb 3, 2005·Journal of Cell Science·Marion ScharpfeneckerHellmut G Augustin
Jun 25, 2005·American Journal of Respiratory and Critical Care Medicine·Ellen L BurnhamMarc Moss
Mar 7, 2006·Infection·A Dalhoff
May 26, 2006·The American Journal of Pathology·Elena Gonzalez-ReyMario Delgado
Jun 10, 2006·Cellular and Molecular Neurobiology·Masaru HondaMasami Niwa
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN American Thoracic Society
Feb 24, 2007·Intensive Care Medicine·Bettina Temmesfeld-WollbrückStefan Hippenstiel
Feb 27, 2007·American Journal of Respiratory and Critical Care Medicine·Sarah D McCarterDuncan J Stewart
Jun 6, 2007·Respiratory Medicine·Hartmut M Lode
Jun 15, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Takefumi ItohNoritoshi Nagaya
Jun 15, 2007·The Journal of Biological Chemistry·Tadanori MammotoVikas P Sukhatme
Aug 11, 2007·The European Respiratory Journal·C Garcia-VidalJ Garau
Nov 15, 2007·Thrombosis and Haemostasis·Bettina Temmesfeld-WollbrückStefan Hippenstiel
Dec 22, 2007·The Journal of Clinical Investigation·Yuka Ichikawa-ShindoTakayuki Shindo
Sep 5, 2008·The European Respiratory Journal·M I RestrepoA Anzueto
Nov 13, 2008·The New England Journal of Medicine·Daniel TalmorStephen H Loring
Apr 21, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Giorgio ZanottiThomas M Egan

❮ Previous
Next ❯

Citations

May 10, 2017·Expert Opinion on Pharmacotherapy·Mario CazzolaMaria Gabriella Matera
Mar 16, 2018·IEEE Journal of Translational Engineering in Health and Medicine·Israr Bin M IbrahimKevin R Ward
Feb 18, 2017·IEEE Journal of Biomedical and Health Informatics·Israr Bin M IbrahimRamana M Pidaparti
Oct 1, 2020·American Journal of Physiology. Lung Cellular and Molecular Physiology·Martin Witzenrath, Wolfgang Michael Kuebler
Sep 19, 2020·Risk Management and Healthcare Policy·Shin-Hong ChenMeng-Yu Wu
May 8, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Luciana P TavaresFrancesca Levi-Schaffer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.